Scientific Partnerships lie at the very core of Exscalate
Partnering with open innovation
Taking a co-development approach
Partnerships that drive results
Exscalate is more than a technology platform, it’s people we collaborate with. By supporting partners with our expertise of drug development, including the mapping of allosteric sites, together with the power of the platform we can drive results. These results are evident from our pipeline of projects, which are either co-developed with a biopharma company or start-up, wholly owned or are a collaboration with an academic institution or research network.
Meet Our Partners
Why is the collaboration with Exscalate important for drug discovery?
Discover more in the interview with Torsten Schwede, Vice President for Research - University of Basel.
How did the collaboration with Exscalate come about?
Discover more in the interview with Giulio Vistoli, Full Professor in Medicinal Chemistry at University of Milan.
What challenges are you facing through the collaboration with Exscalate?
Discover more in the interview with Gianluca Palermo, Full Professor at Politecnico di Milano.
What benefits is AI bringing in the computational field related to generating predictive models?
Discover more in the interview with Pieter Stouten, Computational Technologies in Pharma.